European Journal of Cancer
Volume 38, Issue 10 , Pages 1343-1347 , July 2002

High expression of DNA topoisomerase IIα and Ki-67 antigen is associated with prolonged survival in glioblastoma patients

  • Markus Bredel

      Affiliations

    • Institute of Neurology, University of Vienna, AKH 4J, Währinger Gürtel 18-20, POB 48, A-1097 Vienna, Austria
    • Present address: Department of General Neurosurgery, Neurocenter, University of Freiburg, Germany.
    • ,
  • Maria Piribauer

      Affiliations

    • Department of Internal Medicine I—Oncology, University of Vienna, A-1097 Vienna, Austria
    • ,
  • Christine Marosi

      Affiliations

    • Department of Internal Medicine I—Oncology, University of Vienna, A-1097 Vienna, Austria
    • ,
  • Peter Birner

      Affiliations

    • Institute of Clinical Pathology, University of Vienna, A-1097 Vienna, Austria
    • ,
  • Brigitte Gatterbauer

      Affiliations

    • Department of Neurosurgery, University of Vienna, A-1097 Vienna, Austria
    • ,
  • Ingeborg Fischer

      Affiliations

    • Institute of Neurology, University of Vienna, AKH 4J, Währinger Gürtel 18-20, POB 48, A-1097 Vienna, Austria
    • ,
  • Thomas Ströbel

      Affiliations

    • Institute of Neurology, University of Vienna, AKH 4J, Währinger Gürtel 18-20, POB 48, A-1097 Vienna, Austria
    • ,
  • Karl Rössler

      Affiliations

    • Department of Neurosurgery, University of Vienna, A-1097 Vienna, Austria
    • ,
  • Herbert Budka

      Affiliations

    • Institute of Neurology, University of Vienna, AKH 4J, Währinger Gürtel 18-20, POB 48, A-1097 Vienna, Austria
    • ,
  • Johannes A. Hainfellner

      Affiliations

    • Institute of Neurology, University of Vienna, AKH 4J, Währinger Gürtel 18-20, POB 48, A-1097 Vienna, Austria
    • Corresponding Author InformationCorresponding author. Tel.: +43-1-40400-5507 or -5501; fax: +43-1-40400-5511

Received 24 September 2001 ,Revised 7 December 2001 ,Accepted 15 February 2002.

References 

  1. Cavalla P, Schiffer D. Cell cycle and proliferation markers in neuroepithelial tumors. Anticancer Res. 1997;17:4135–4143
  2. McKeever PE. Insights about brain tumors gained through immunohistochemistry and in situ hybridization of nuclear and phenotypicmarkers. J. Histochem. Cytochem. 1998;46:585–594
  3. Kordek R, Biernat W, Alwasiak J, Liberski PP. Proliferating cell nuclear antigen (PCNA) and Ki-67 immunopositivity in human astrocytic tumours. Acta Neurochir. 1996;138:509–512
  4. Holden JA, Townsend JJ. DNA topoisomerase II-alpha as a proliferation marker in astrocytic neoplasms of the central nervous system: correlation with MIB-1 expression and patient survival. Mod. Pathol. 1999;12:1094–1100
  5. Taniguchi K, Wakabayashi T, Yoshida T, et al.  Immunohistochemical staining of DNA topoisomerase IIalpha in human gliomas. J. Neurosurg. 1999;91:477–482
  6. Di X, Nishizaki T, Harada K, Kajiwara K, Nakayama H, Ito H. Proliferative potentials of glioma cells and vascular components determined with monoclonal antibody MIB-1. J. Exp. Clin. Cancer Res. 1997;16:153–157
  7. Enestrom S, Vavruch L, Franlund B, Nordenskjold B. Ki-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas. Neurochirurgie. 1998;44:25–30
  8. Kirkegaard LJ, DeRose PB, Yao B, Cohen C. Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas. Prognostic significance. Am. J. Clin. Pathol. 1998;109:69–74
  9. Kirla R, Salminen E, Huhtala S, et al.  Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy. J. Neuro-Oncol. 2000;46:71–80
  10. Mastronardi L, Guiducci A, Puzzilli F, Ruggeri A. Relationship between Ki-67 labeling index and survival in high-grade glioma patients treated after surgery with tamoxifen. J. Neurosurg. Sci. 1999;43:263–270
  11. Montine TJ, Vandersteenhoven JJ, Aguzzi A, et al.  Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery. 1994;34:674–678
  12. Torp SH, Helseth E, Dalen A, Unsgaard G. Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas. Acta Neurochir. 1992;117:182–186
  13. Wakimoto, H., Aoyagi M., Nakayama T., et al. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Cancer 1996, 77, 373–80.
  14. Bouvier Labit C, Chinot O, Ochi C, Gambarelli D, Dufour H, Figarella Branger D. Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas. Neuropathol. Appl. Neurobiol. 1998;24:381–388
  15. Ellison DW, Steart PV, Bateman AC, Pickering RM, Palmer JD, Weller RO. Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies. J. Neurol. Neurosurg. Psychiatry. 1995;59:413–419
  16. Heesters MA, Koudstaal J, Go KG, Molenaar WM. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value. J. Neuro-Oncol. 1999;44:255–266
  17. Litofsky NS, Mix TC, Baker SP, Recht LD, Smith TW. Ki-67 (clone M.I.B.-1) proliferation index in recurrent glial neoplasms: no prognostic significance. Surg. Neurol. 1998;50:579–585
  18. Pigott TJ, Lowe JS, Palmer J. Statistical modelling in analysis of prognosis in glioblastoma multiforme (a study of clinical variables and Ki-67 index). Br. J. Neurosurg. 1991;5:61–66
  19. Vaquero J, Zurita M, Morales C, Oya S, Coca S. Prognostic significance of endothelial surface score and MIB-1 labelling index in glioblastoma. J. Neuro-Oncol. 2000;46:11–16
  20. Bredel M. Anticancer drug resistance in primary human brain tumors. Brain Res. Rev. 2001;35:161–204
  21. Kleihues P, Cavenee WK. World Health Organization Classification of Tumours (Pathology and Genetics of Tumours of the Nervous System). Lyon: IARC Press; 2000;
  22. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958;53:457–481
  23. Cox DR. Regression models and life tables. J. R. Stat. Soc. B. 1972;34:187–220
  24. McKeever PE, Junck L, Strawderman MS, et al.  Proliferation index is related to patient age in glioblastoma. Neurology. 2001;56:1216–1218
  25. Stemmer Rachamimov AO, Louis DN. Histopathologic and immunohistochemical prognostic factors in malignant gliomas. Curr. Opin. Oncol. 1997;9:230–234
  26. Pine JW. Cancer Medicine 1. Baltimore, USA: Williams & Wilkins; 1997;
  27. Czader M, Mazur J, Pettersson M, et al.  Prognostic significance of proliferative and apoptotic fractions in low grade follicle center cell-derived non-Hodgkin's lymphomas. Cancer. 1996;77:1180–1188

PII: S0959-8049(02)00065-5

European Journal of Cancer
Volume 38, Issue 10 , Pages 1343-1347 , July 2002

Article Tools

* Image Usage & Resolution